Study Identifies Risk Factors For Invasive Fungal Infections Among Patients Receiving Ibrutinib Therapy
January 03, 2024
Infectious Disease Advisor (1/2, Barowski) reports, “Among patients receiving ibrutinib, allogeneic or autologous stem cell transplantation, chronic respiratory disease, and use of anti-CD20 agents or corticosteroids may increase risk for invasive fungal infections, according to study results.” The findings were published in Mycoses.